Aegea

Aegea Biotechnologies is a private molecular diagnostics and life science tools company focused on nucleic acid technologies for ultra-sensitive mutation detection. Its core Switch-Blocker platform is designed to suppress wild-type DNA or RNA and enrich rare variants, enabling improved performance in PCR, next-generation sequencing, and microarray workflows. The company develops reagents, research kits, assay solutions, and in vitro diagnostic products for applications including oncology, infectious diseases, transplantation, and precision medicine. Rather than a therapeutic drug developer, Aegea appears to operate as a platform and products company serving diagnostics, genomics, and biopharma customers. The business is based in the San Diego area and emphasizes compatibility with existing lab instrumentation and workflows.